drugset / Trial / NCT01020799
AZD7268 Safety and Tolerability Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to prove the principle that treatment with AZD7268 reduces depressive symptoms in patients with Major Depressive Disorder (MDD) compared with placebo.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7268 | Small molecule | 15 mg | Oral |
| Comparator | Escitalopram | Small molecule | 20 mg | Oral |